Document is current

Article History

Received: 17 May 2023

Accepted: 31 July 2023

First Online: 11 September 2023

Declarations

:

: Ethical clearance was obtained from Bahir Dar University, College of medicine and Health sciences ethical review board with Ref No. 353/2021, and clinical trial registration was completed (Clinical Trials.gov ID of NCT05236452). Informed consent and assent will be obtained from adult and pediatric participants, respectively. The purpose of the study will be explained to the study participants and respected officials, and then, permission will be obtained from the respected officials. Participants will also be asked for their consent to allow the research team to share pertinent data with members of the sponsors, participating institutions, or regulatory authorities, as appropriate.This trial does not involve collecting biological specimens for storage. Participants will not be enforced in any way to take part in the study. Personal identifiers will not be included to ensure the confidentiality of participants. Written consent and assent forms are prepared and are annexed in Appendix InternalRef removed and Appendix InternalRef removed, respectively.

: Not applicable.

: The authors declare that they have no competing interests.